Skip to main content
. 2007 Oct 1;9(5):404–410. doi: 10.1016/j.jfms.2007.04.004

Table 2.

Percentage of susceptible aerobic and facultatively anaerobic isolates (n=number of samples)

Antibiotics Overall efficacy (%) Gram-positive (%) Gram-negative (%)
Doxycycline 45.1 (n=51) 68.2 (n=22) 25.9 (n=27)
Trimethoprim+sulphonamide 47.1 (n=51) 41.7 (n=24) 48.1 (n=27)
Ampicillin/amoxycillin 31.9 (n=47) 40.9 (n=22) 20.0 (n=25)
Amoxycillin+clavulanic acid 63.6 (n=44) 86.4 (n=22) 40.9 (n=22)
Gentamicin 66.7 (n=51) 70.8 (n=24) 59.3 (n=27)
Chloramphenicol 69.4 (n=49) 82.6 (n=23) 50.0 (n=26)
Enrofloxacin 76.5 (n=51) 70.8 (n=24) 74.1 (n=27)
Cephalexin 63.2 (n=38) 65.2 (n=23) 60.0 (n=15)
Lincomycin 38.2 (n=34) 61.9 (n=21) 0.0 (n=13)